Lineage Cell Therapeutics sets 2023 annual meeting for September 6; proposal deadline July 14

Lineage Cell Therapeutics, Inc.

Annual Meeting scheduled for September 6, 2023.
Shareholder proposals and nominations due by July 14, 2023.
Rule 14a-8 proposals for proxy statement also due July 14.

item 8.01

Lineage Cell Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-022030

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.